225 related articles for article (PubMed ID: 20347140)
21. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
Graber-Maier A; Gutmann H; Drewe J
Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
[TBL] [Abstract][Full Text] [Related]
22. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility.
Cygalova LH; Hofman J; Ceckova M; Staud F
J Pharmacol Exp Ther; 2009 Dec; 331(3):1118-25. PubMed ID: 19779128
[TBL] [Abstract][Full Text] [Related]
23. The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis.
Blazquez AG; Briz O; Gonzalez-Sanchez E; Perez MJ; Ghanem CI; Marin JJ
Toxicol Appl Pharmacol; 2014 May; 277(1):77-85. PubMed ID: 24631341
[TBL] [Abstract][Full Text] [Related]
24. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
Pollex E; Lubetsky A; Koren G
Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
[TBL] [Abstract][Full Text] [Related]
25. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line.
Staud F; Vackova Z; Pospechova K; Pavek P; Ceckova M; Libra A; Cygalova L; Nachtigal P; Fendrich Z
J Pharmacol Exp Ther; 2006 Oct; 319(1):53-62. PubMed ID: 16809480
[TBL] [Abstract][Full Text] [Related]
26. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta.
Neumanova Z; Cerveny L; Ceckova M; Staud F
AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260
[TBL] [Abstract][Full Text] [Related]
27. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
Bircsak KM; Gupta V; Yuen PY; Gorczyca L; Weinberger BI; Vetrano AM; Aleksunes LM
J Pharmacol Exp Ther; 2016 Apr; 357(1):103-13. PubMed ID: 26850786
[TBL] [Abstract][Full Text] [Related]
28. Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979.
Shepard RL; Cao J; Starling JJ; Dantzig AH
Int J Cancer; 2003 Jan; 103(1):121-5. PubMed ID: 12455064
[TBL] [Abstract][Full Text] [Related]
29. Maternal bacterial infections impact expression of drug transporters in human placenta.
Petrovic V; Kojovic D; Cressman A; Piquette-Miller M
Int Immunopharmacol; 2015 Jun; 26(2):349-56. PubMed ID: 25912346
[TBL] [Abstract][Full Text] [Related]
30. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
Vaidya SS; Walsh SW; Gerk PM
Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
[TBL] [Abstract][Full Text] [Related]
31. Maternal and Fetal Exposure to (-)-Δ
Chen X; Unadkat JD; Mao Q
Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
[TBL] [Abstract][Full Text] [Related]
32. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA
Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156
[TBL] [Abstract][Full Text] [Related]
33. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction.
Evseenko DA; Murthi P; Paxton JW; Reid G; Emerald BS; Mohankumar KM; Lobie PE; Brennecke SP; Kalionis B; Keelan JA
FASEB J; 2007 Nov; 21(13):3592-605. PubMed ID: 17595345
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
Cascorbi I; Haenisch S
Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
[TBL] [Abstract][Full Text] [Related]
35. Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.
Szilagyi JT; Gorczyca L; Brinker A; Buckley B; Laskin JD; Aleksunes LM
Toxicol Sci; 2019 Apr; 168(2):394-404. PubMed ID: 30576553
[TBL] [Abstract][Full Text] [Related]
36. BCRP/ABCG2 in the placenta: expression, function and regulation.
Mao Q
Pharm Res; 2008 Jun; 25(6):1244-55. PubMed ID: 18202831
[TBL] [Abstract][Full Text] [Related]
37. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
38. P-glycoprotein down-regulates expression of breast cancer resistance protein in a drug-free state.
Bark H; Xu HD; Kim SH; Yun J; Choi CH
FEBS Lett; 2008 Jul; 582(17):2595-600. PubMed ID: 18588889
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population.
Østergaard M; Ernst A; Labouriau R; Dagiliené E; Krarup HB; Christensen M; Thorsgaard N; Jacobsen BA; Tage-Jensen U; Overvad K; Autrup H; Andersen V
Scand J Gastroenterol; 2009; 44(1):65-73. PubMed ID: 18819034
[TBL] [Abstract][Full Text] [Related]
40. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]